DE3008056C2 - - Google Patents

Info

Publication number
DE3008056C2
DE3008056C2 DE3008056A DE3008056A DE3008056C2 DE 3008056 C2 DE3008056 C2 DE 3008056C2 DE 3008056 A DE3008056 A DE 3008056A DE 3008056 A DE3008056 A DE 3008056A DE 3008056 C2 DE3008056 C2 DE 3008056C2
Authority
DE
Germany
Prior art keywords
general formula
known per
manner known
solution
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3008056A
Other languages
German (de)
English (en)
Other versions
DE3008056A1 (de
Inventor
Yasufumi Omiya Saitama Jp Hirata
Isao Tokio/Tokyo Jp Yanagisawa
Yoshio Omiya Saitama Jp Ishii
Masaaki Urawa Saitama Jp Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2574579A external-priority patent/JPS55118476A/ja
Priority claimed from JP7950879A external-priority patent/JPS565469A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE3008056A1 publication Critical patent/DE3008056A1/de
Application granted granted Critical
Publication of DE3008056C2 publication Critical patent/DE3008056C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE19803008056 1979-03-06 1980-03-03 Guanidinothiazolverbindungen, verfahren zu ihrer herstellung und arzneimittel Granted DE3008056A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2574579A JPS55118476A (en) 1979-03-06 1979-03-06 Novel amidine derivative and its preparation
JP7950879A JPS565469A (en) 1979-06-23 1979-06-23 Novel amidine derivative and its preparation
KR1019800000932A KR830002478B1 (ko) 1979-03-06 1980-03-06 구아니디노 티아졸 화합물의 제조방법

Publications (2)

Publication Number Publication Date
DE3008056A1 DE3008056A1 (de) 1980-09-18
DE3008056C2 true DE3008056C2 (en, 2012) 1988-07-21

Family

ID=27285138

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803008056 Granted DE3008056A1 (de) 1979-03-06 1980-03-03 Guanidinothiazolverbindungen, verfahren zu ihrer herstellung und arzneimittel

Country Status (11)

Country Link
US (1) US4362736A (en, 2012)
CA (1) CA1145345A (en, 2012)
CH (1) CH644114A5 (en, 2012)
DE (1) DE3008056A1 (en, 2012)
ES (1) ES489222A0 (en, 2012)
FR (1) FR2450827A1 (en, 2012)
GB (1) GB2052478B (en, 2012)
IT (1) IT1165509B (en, 2012)
NL (1) NL8001361A (en, 2012)
PH (1) PH16099A (en, 2012)
SE (1) SE447253B (en, 2012)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IN158869B (en, 2012) * 1981-03-18 1987-02-07 Ici Plc
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
JPS5872571A (ja) * 1981-10-27 1983-04-30 Shionogi & Co Ltd ２−グアニジノ−４−〔２−（ホルムアミド）エチルチオメチル〕チアゾ−ルの製法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0103390A3 (en) * 1982-08-13 1986-02-26 Imperial Chemical Industries Plc Guanidine-containing esters as histamine h2 receptor blockers
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JPS6160673A (ja) * 1984-08-30 1986-03-28 Yamanouchi Pharmaceut Co Ltd グアニジノチアゾ−ル誘導体の製造法
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
EP0284536A1 (en) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile
US5428033A (en) 1990-10-12 1995-06-27 Merck Frosst Canada, Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
JP6378179B2 (ja) 2013-07-03 2018-08-22 株式会社新日本科学 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
WO2021183259A1 (en) * 2020-03-12 2021-09-16 Nanopharmaceutics, Inc. Famotidine and famotidine analogs for corona virus treatment
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817078C2 (de) * 1977-04-20 1995-06-14 Zeneca Ltd Guanidinderivate
NO781300L (no) * 1977-04-20 1978-10-23 Ici Ltd Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法

Also Published As

Publication number Publication date
PH16099A (en) 1983-06-24
FR2450827B1 (en, 2012) 1983-03-25
IT8067346A0 (it) 1980-03-05
IT1165509B (it) 1987-04-22
ES8103070A1 (es) 1981-02-16
NL8001361A (nl) 1980-09-09
GB2052478B (en) 1983-04-07
CH644114A5 (de) 1984-07-13
GB2052478A (en) 1981-01-28
CA1145345A (en) 1983-04-26
FR2450827A1 (fr) 1980-10-03
DE3008056A1 (de) 1980-09-18
US4362736A (en) 1982-12-07
ES489222A0 (es) 1981-02-16
SE8001691L (sv) 1980-09-07
SE447253B (sv) 1986-11-03

Similar Documents

Publication Publication Date Title
DE3008056C2 (en, 2012)
DE2951675C2 (de) Guanidinothiazolverbindungen, Verfahren zu deren Herstellung und Arzneimittelzubereitungen
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2634429A1 (de) Cyclobutendion- und -dithionderivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2835695A1 (de) Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE1967080C3 (de) t-(3,4-Methylendioxybeiizoyl)-2methyl-5-methoxy-3-indolylessigsäureester, Verfahren zu ihrer Herstellung und Arzneipräparate
CH638215A5 (de) Oxadiazolopyrimidin-derivate.
DE2313256C3 (de) l^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3413875A1 (de) Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
EP0037471B1 (de) 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel
EP0219747B1 (de) Neue 2-(2-Thienyl)-imidazo(4,5-c)pyridinderivate und deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2605824A1 (de) N-acylaniline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3413876A1 (de) Arzneimittel
DE2525725A1 (de) Substituierte 4-phenyl-imidazoline, deren saeureadditionssalze und verfahren zu ihrer herstellung
DE3022302A1 (de) Pyridylaminotriazole und solche verbindungen enthaltende arzneimittel
DE3513184A1 (de) 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AT325620B (de) Verfahren zur herstellung von neuen triazolothienodiazepinverbindungen und deren säureadditionssalzen
DE3125216C2 (de) N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten
EP0111205B1 (de) Acridanon-Derivate
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2301527A1 (de) 1-aminopyrazole, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE4119755A1 (de) Aminoalkylsubstituierte 2-amino-1,3,4-thiadiazole, ihre herstellung und verwendung
DE2012667B2 (de) carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate
AT368146B (de) Verfahren zur herstellung neuer 2-anilinooxazoline

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee